THE WOODLANDS, Texas, Feb. 14 /PRNewswire/ -- Lexicon Genetics Incorporated announced today the appointment of Julia P. Gregory as Executive Vice President and Chief Financial Officer. Before joining Lexicon, Ms. Gregory was the Head of Investment Banking for Punk, Ziegel, & Company in New York and Head of the firm's Life Sciences practice. From 1980 to 1996, Ms. Gregory was an investment banker with Prime Charter Ltd. and Dillon, Read & Co., Inc. She has represented life sciences companies since 1986. Ms. Gregory is a member of the Emerging Company Section Governing Body of the Biotech Industry Organization and was on Bio's Advisory Board for the February 2000 CEO and Investor Conference in New York. Ms. Gregory is also a member of the Executive Committee of the Lauder Foundation's Institute for the Study of Aging, Inc. She received her B.A. in International Affairs from George Washington University where she was elected to Phi Beta Kappa and her M.B.A. from the Wharton School of the University of Pennsylvania.

Lexicon Genetics Incorporated (www.lexicon-genetics.com) is a pioneer in the design, development and application of high-throughput gene trapping and mutagenesis technologies for gene discovery and functional genomics. Lexicon employs its proprietary Human Gene Trap(TM) database, OmniBank(R) library of gene-trapped mouse clones and its Internet-based bioinformatics software in an integrated technology platform for drug discovery and drug target validation. Lexicon has an agreement with Millennium Pharmaceuticals, Inc. for access to the Human Gene Trap and OmniBank databases. Lexicon has commercial OmniBank alliances with ZymoGenetics/Novo Nordisk and DuPont Pharmaceuticals. Lexicon Genetics Incorporated, founded in 1995, is a privately-held company based in The Woodlands, Texas, U.S.A.